Intrathecal Neostigmine for Prevention of PDPH
NCT03587441
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Post-Dural Puncture Headache
Interventions
DRUG:
Neostigmine Methylsulfate
DRUG:
Dextrose 5% in water
Sponsor
Fayoum University Hospital